Soley Bayraktar Selected Research

Soley Bayraktar Research Topics

Disease

16	Neoplasms (Cancer) 10/2021 - 02/2010
16	Breast Neoplasms (Breast Cancer) 11/2020 - 09/2011
4	Adenocarcinoma 04/2014 - 11/2010
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014 - 02/2010
3	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 07/2010
3	Pathologic Complete Response 05/2012 - 10/2011
2	Neutropenia 01/2020 - 09/2014
2	Vomiting 01/2020 - 09/2014
2	Nausea 01/2020 - 09/2014
2	Edema (Dropsy) 09/2014 - 01/2010
2	Anemia 09/2014 - 06/2010
2	Lymphoma (Lymphomas) 04/2014 - 10/2010
2	Triple Negative Breast Neoplasms 02/2013 - 09/2012
2	Carcinogenesis 12/2012 - 11/2011
2	Neoplasm Metastasis (Metastasis) 03/2012 - 11/2010
1	Myasthenia Gravis 10/2021
1	Margins of Excision 10/2021
1	Diabetes Mellitus 10/2021
1	Thymoma (Thymic Carcinoma) 10/2021
1	Disease Progression 11/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Exanthema (Rash) 01/2020
1	Stomatitis 01/2020
1	Hyperplasia 01/2020
1	Acne Vulgaris 01/2020
1	Breast Carcinoma In Situ 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 02/2017
1	Anorexia 09/2014
1	Pain (Aches) 09/2014
1	Injection Site Reaction 09/2014
1	Erythema 09/2014
1	Abscess 09/2014
1	Diarrhea 09/2014
1	Constipation 09/2014
1	Fatigue 09/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013
1	Hypersensitivity (Allergy) 01/2013
1	Stomach Neoplasms (Stomach Cancer) 09/2012

Drug/Important Bio-Agent (IBA)

4	Trastuzumab (Herceptin)FDA Link 01/2019 - 05/2012
4	Capecitabine (Xeloda)FDA Link 01/2019 - 02/2010
4	AnthracyclinesIBA 01/2019 - 05/2012
4	Docetaxel (Taxotere)FDA Link 10/2014 - 05/2012
4	Gemcitabine FDA Link 04/2014 - 02/2010
3	taxaneIBA 01/2020 - 09/2012
3	Progesterone Receptors (Progesterone Receptor)IBA 07/2013 - 09/2011
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2020
2	Hormones (Hormone)IBA 11/2020 - 05/2012
2	Estrogen ReceptorsIBA 01/2020 - 09/2011
2	Epidermal Growth Factor (EGF)IBA 01/2019 - 02/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 09/2012
2	Bevacizumab (Avastin)FDA Link 12/2012 - 11/2010
2	Fluorouracil (Carac)FDA LinkGeneric 09/2012 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 09/2012 - 11/2011
2	GenisteinIBA 11/2011 - 06/2010
2	LycopeneIBA 11/2011 - 06/2010
1	Capsules (Microcapsules)IBA 10/2021
1	abemaciclibIBA 11/2020
1	palbociclibIBA 11/2020
1	ribociclibIBA 11/2020
1	Taxoids (Taxanes)IBA 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	neratinibIBA 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2014
1	Zidovudine (Retrovir)FDA LinkGeneric 04/2014
1	Hydroxyurea (Hydrea)FDA LinkGeneric 04/2014
1	Methotrexate (Mexate)FDA LinkGeneric 04/2014
1	Thymidine KinaseIBA 04/2014
1	Estrogens (Estrogen)FDA Link 02/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2013
1	Phosphotransferases (Kinase)IBA 12/2012
1	drozitumabIBA 12/2012
1	Platinum Compounds (Compounds, Platinum)IBA 09/2012
1	Cisplatin (Platino)FDA LinkGeneric 09/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2012
1	Carboplatin (JM8)FDA LinkGeneric 05/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2012
1	Metformin (Glucophage)FDA LinkGeneric 03/2012
1	IsoflavonesIBA 11/2011
1	Caspase 9IBA 11/2011
1	8-epi-prostaglandin F2alphaIBA 11/2011
1	anthraceneIBA 11/2011
1	benz(a)anthracene (benzanthracene)IBA 11/2011
1	Carotenoids (Carotene)IBA 11/2011
1	Caspase 3 (Caspase-3)IBA 11/2011
1	CarcinogensIBA 11/2011

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 10/2021 - 01/2010
11	Therapeutics 10/2021 - 01/2010
5	Neoadjuvant Therapy 10/2014 - 07/2010
4	Adjuvant Chemotherapy 01/2019 - 07/2010
3	Chemoprevention 01/2020 - 06/2010
1	Length of Stay 10/2021
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Adjuvant Radiotherapy 10/2021
1	Immunotherapy 01/2019
1	Mastectomy (Mammectomy) 02/2017
1	Salpingo-oophorectomy 02/2017